Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...
DNA gene

Sweet gene victory around the corner? Therapeutic advances come rolling in

As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...
Farmer with cattle in Cambodia

More investments and surveillance needed to curb misuse of antimicrobials in public health and...

Addressing the Antimicrobial Resistance (AMR) challenge requires a stronger collaborative effort across sectors New York, 21 September 2017 - A stronger global effort, including larger investments...
Emma Walmsley - CEO of GSK

Emma’s marvellous medicine

GlaxoSmithKline’s mighty empire faces a new chapter with the retirement of Sir Andrew Witty A MOTHER-of-four from the gritty industrial town of Barrow-in-Furness will create...